Inherited cancer syndromes in children and young adults

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Geneticists estimate that 5% to 10% of all cancers diagnosed in the pediatric age range occur in children born with a genetic mutation that directly increases their lifetime risk for neoplasia. However, despite the fact that only a fraction of cancers in children occur as a result of an identified inherited predisposition, characterizing genetic mutations responsible for increased cancer risk in such syndromes has resulted in a profound understanding of relevant molecular pathways involved in carcinogenesis and/or resistance to neoplasia. Importantly, because most cancer predisposition syndromes result in an increased risk of a small number of defined malignancies, personalized prophylactic surveillance and preventive measures can be implemented in affected patients. Lastly, many of the same genetic targets identified from cancer-prone families are mechanistically involved in the majority of sporadic cancers in adults and children, thereby underscoring the clinical relevance of knowledge gained from these defined syndromes and introducing novel therapeutic opportunities to the broader oncologic community. This review highlights the clinical and genetic features of many of the known constitutional genetic syndromes that predispose to malignancy in children and young adults.

Original languageEnglish
Pages (from-to)195-228
Number of pages34
JournalJournal of Pediatric Hematology/Oncology
Issue number3
StatePublished - Apr 2010


  • Familial cancer
  • Genetics
  • Oncology
  • Pediatric
  • Predisposition
  • Syndrome
  • Tumor

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology


Dive into the research topics of 'Inherited cancer syndromes in children and young adults'. Together they form a unique fingerprint.

Cite this